LKY-047 is a decursin derivative that acts as a potent, selective, reversible, and competitive inhibitor of cytochrome P450 2J2 (CYP2J2), with an IC50 of 1.7 μM; it shows no inhibitory activity against other human P450 enzymes, including CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A.